About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
March 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: Proposed Legislation
This is Your State – This is Your State on Drugs – an Ongoing Series
One of the considerable elements re-shaping the marketing of pharmaceuticals in the United States has been the outlooks and activities and probable future legislation under advisement by members of Congress. While the various actions at the federal level have dominated … Continue reading
Posted in Proposed Legislation
Comments Off on This is Your State – This is Your State on Drugs – an Ongoing Series
Taking the F out of FDA….
Twice with in the past week, the New York Times has carried an article referencing the desire among some to split the Food and Drug Administration into two parts, one that oversees food and one that oversees drugs. On … Continue reading
Posted in Food, Proposed Legislation
3 Comments
PDUFA IV
As we all wait anxiously for Congress to do its job and actually produce legislation for signature, and as many FDA employees see their jobs hanging in the balance while awaiting PDUFA IV, some may wonder what it is all … Continue reading
Posted in Proposed Legislation
Comments Off on PDUFA IV
The Senators, the FDA, the Company and The Access to Medicare Data Act of 2007
This year, Senators Charles Grassley (R-Iowa) and Max Baucus (D-Mont) have been on more of a tear than usual regarding the FDA. A lot of their focus this year has been on post-marketing surveillance of drugs and devices. They are … Continue reading
Posted in Drug Safety, Proposed Legislation
2 Comments
What a Ban on DTC Means for Public Relations
There have been several proposals before Congress which, in one way or another, have the potential to impact the amount of direct-to-consumer advertising (DTC) allowed. Some would give the FDA authority to restrict such advertising. Others have called for it … Continue reading
Posted in DTC Advertising, Proposed Legislation
Comments Off on What a Ban on DTC Means for Public Relations